Vlachakis N D, Mendlowitz M
Am Heart J. 1976 Dec;92(6):750-7. doi: 10.1016/s0002-8703(76)80012-9.
The efficacy and side effects of the combined administration of propranolol and phenoxybenzamine were examined in 19 patients with moderate and moderately severe essential hypertension. By titrating the dosage of both drugs against pulse rate and blood pressure response, propranolol was given between 80 and 160 mg. and phenoxybenzamine between 20 and 50 mg. per day in divided doses. There was a substantial reduction in both systolic and diastolic blood pressure in both recumbent and upright positions without orthostatic hypotension. Normal blood pressure (140/90 mm. Hg or less) or near normal (150/100 mm. Hg or less) was attained in 14 of the patients in the recumbent and 17 in the upright position. Pulse rate also decreased significantly, whereas body weight increased but not significantly so. Except for a reduction of ejaculation in three out of six male subjects, no symptomatic side effects were detected, and no changes in the liver or renal function or in blood count were observed. Despite the short duration of therapy, 3 to 10 weeks, this study clearly demonstrates that propranolol and phenoxybenzamine given together in individualized doses are very effective in lowering arterial blood pressure with minimal side effects.
对19例中度和中度重度原发性高血压患者联合应用普萘洛尔和酚苄明的疗效及副作用进行了研究。通过根据脉搏率和血压反应调整两种药物的剂量,普萘洛尔的用量为每日80至160毫克,酚苄明的用量为每日20至50毫克,均分剂量服用。仰卧位和直立位的收缩压和舒张压均显著降低,且无直立性低血压。14例患者仰卧位血压达到正常(140/90毫米汞柱或更低)或接近正常(150/100毫米汞柱或更低),17例患者直立位血压达到正常或接近正常。脉搏率也显著下降,而体重增加但不显著。除6名男性受试者中有3人射精减少外,未发现有症状的副作用,也未观察到肝功能、肾功能或血细胞计数的变化。尽管治疗时间较短,仅3至10周,但本研究清楚地表明,个体化剂量联合应用普萘洛尔和酚苄明在降低动脉血压方面非常有效,且副作用最小。